The ARC Centre of Excellence in Exciton Science focuses on three core activities.
- Research: deliver high quality research outcomes.
- Translations: make an impact on industry and inspire the next generation of researchers.
- Administration: use public resources effectively to achieve the mission of the Centre.
The Director is Professor Paul Mulvaney. He is supported by an Executive Committee representing the core activities.
An Advisory Board, with experts in each of the core activities, provides oversight to ensure that ACEx is meeting its goals. The Advisory Board is chaired by Professor Margaret Sheil, Provost of the University of Melbourne, former CEO of the Australian Research Council, and Professor of Chemistry.
The Executive Committee is responsible for reviewing the strategic direction of the Centre, assessing progress against projected milestones and implementing strategic changes to the Centre’s research directions or operation.
The Executive Committee comprises:
- Prof. Paul Mulvaney as the Chair (Director)
- Prof. Udo Bach (Deputy Director)
- Assoc. Prof. Dane McCamey (Outreach, Education and Governance Director)
- the Research Theme Leaders
- one Capability Leader
- the Business Development Manager
- the Centre Chief Operating Officer
Centre Advisory Board
The Centre Advisory Board will review all aspects of the Centre’s operations, including administrative functions, strategic planning and decision making, intellectual property, outreach and commercial translation. Members include:
Prof. Marc Parlange, Provost and Senior Vice-President, Monash University
International Scientific Advisory Committee
This Committee provides scientific oversight and advice to the Centre. Members include:
Four basic research capabilities underpin the Centre’s ability to achieve its research goals, each with a designated capability leader and deputy:
Research Theme Leaders
Each of the three Research Themes is led by a Theme Leader and a Deputy. Theme Leaders are members of the Executive Committee. In this capacity they continually assess the progress and value of each research platform, identify platforms which should be proposed for removal, and propose new platforms to the Executive Committee as opportunity arises.